SIC 2834 – Pharmaceutical Preparations
Valuation | |
---|---|
Market Cap ($M) | 62.72 |
Enterprise Value ($M) | 103.25 |
Book Value ($M) | 27.81 |
Book Value / Share | 1.26 |
Price / Book | 2.26 |
NCAV ($M) | -89.95 |
NCAV / Share | -4.09 |
Price / NCAV | -0.70 |
Profitability (mra) | |
---|---|
Return on Invested Capital (ROIC) | -1.19 |
Return on Assets (ROA) | -0.72 |
Return on Equity (ROE) | -3.73 |
Liquidity (mrq) | |
---|---|
Quick Ratio | 0.22 |
Current Ratio | 0.26 |
Balance Sheet (mrq) ($M) | |
---|---|
Current Assets | 17.73 |
Assets | 135.49 |
Liabilities | 107.68 |
Debt | n/a |
Equity | n/a |
Income Statement (mra) ($M) | |
---|---|
Revenue | 0.00 |
Operating Income | 0.00 |
Net Income | 0.00 |
Earnings Per Share Basic And Diluted | n/a |
Cash Flow Statement (mra) ($M) | |
---|---|
Cash From Operations | 0.00 |
Cash from Investing | 0.00 |
Cash from Financing | 0.00 |
(click for more detail) |
File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
---|---|---|---|---|
13D/A | Dragasac Ltd | 34.20 | -89.64 | |
13G/A | UNITED THERAPEUTICS Corp | 4.11 | 0.00 |
Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
---|---|---|---|---|
(click for more detail) |
Date | Insider Trades | Code | Shares | Value |
---|---|---|---|---|
(click for more detail) |
File Date | Form | SEC Filings |
---|---|---|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K | ||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
(click for more detail) |
Short Volume | |||
---|---|---|---|
Market Date | Short Volume | Total Volume | Short Volume Ratio |
16,937 | 103,520 | 16.36 | |
28,237 | 91,594 | 30.83 | |
28,003 | 116,655 | 24.00 | |
49,152 | 250,737 | 19.60 | |
122,301 | 479,021 | 25.53 | |
(click for more detail) |
Similar Companies | |
---|---|
CDMO – Avid Bioservices, Inc. | CDTX – Cidara Therapeutics, Inc. |
CDXC – ChromaDex Corporation | CELZ – Creative Medical Technology Holdings, Inc. |
CGEN – Compugen Ltd. |
Financial data and stock pages provided by
Fintel.io